| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-09 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |